Afya Dividendi e riacquisti

Dividendo criteri di controllo 0/6

Afya non ha registrato alcun pagamento di dividendi.

Informazioni chiave

n/a

Rendimento del dividendo

-0.1%

Rendimento del riacquisto

Rendimento totale per gli azionisti	-0.1%
Rendimento futuro dei dividendi	0.4%
Crescita dei dividendi	n/a
Prossima data di pagamento dei dividendi	n/a
Data di stacco del dividendo	n/a
Dividendo per azione	n/a
Rapporto di remunerazione	n/a

Aggiornamenti recenti su dividendi e riacquisti

Nessun aggiornamento

Recent updates

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Aug 29

Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Aug 29

Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Aug 15

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Jul 17

Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 20

Afya's Results Are Improving And The Market Is Undervaluing It

Jun 06

Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

May 14

AFYA: Mr Market Is Mistaken

Apr 29

Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Apr 27

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Apr 09

Afya Is Performing Well And Is A Buy

Mar 19

Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Mar 17

Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Feb 10

Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Jan 21

Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

Jan 03

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Dec 07

Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

Nov 02

What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Sep 20

Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Aug 17

Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance

Aug 23

White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth

Jul 28

Afya: Margin And Organic Growth Struggles Remain Top Of Mind

Apr 14

Afya On A Grey Price Area

Dec 25

Afya: The Longer-Term Growth Story Remains Intact

Sep 19

Afya to acquire UNIGRANRIO for R$700M

May 27

Here's Why I Think Afya (NASDAQ:AFYA) Is An Interesting Stock

Apr 04

Is Afya Limited's (NASDAQ:AFYA) ROE Of 11% Impressive?

Mar 09

Is Afya (NASDAQ:AFYA) Using Too Much Debt?

Feb 16

A Look At The Intrinsic Value Of Afya Limited (NASDAQ:AFYA)

Jan 29

The Trends At Afya (NASDAQ:AFYA) That You Should Know About

Jan 12

What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 24

Afya BOD approves share buyback program

Dec 23

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Dati insufficienti per determinare se i dividendi per azione di AFYA siano rimasti stabili in passato.

Dividendo in crescita: Dati insufficienti per determinare se i pagamenti dei dividendi di AFYA siano aumentati.

Rendimento dei dividendi rispetto al mercato

Afya Rendimento dei dividendi rispetto al mercato

Come si colloca il rendimento da dividendo di AFYA rispetto al mercato?
Segmento	Rendimento dei dividendi
Azienda (AFYA)	n/a
Fondo del 25% del mercato (US)	1.4%
Top 25% del mercato (US)	4.2%
Media del settore (Consumer Services)	2.0%
Analista previsionale (AFYA) (fino a 3 anni)	0.4%

Dividendo notevole: Impossibile valutare il rendimento dei dividendi di AFYA rispetto al 25% inferiore dei pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Dividendo elevato: Impossibile valutare il rendimento dei dividendi di AFYA rispetto al 25% dei maggiori pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Distribuzione degli utili agli azionisti

Copertura degli utili: Dati insufficienti per calcolare il payout ratio di AFYA per determinare se i suoi pagamenti di dividendi sono coperti dagli utili.

Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Impossibile calcolare la sostenibilità dei dividendi poiché AFYA non ha segnalato alcun pagamento.

Afya Dividendi e riacquisti

Dividendo criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti su dividendi e riacquisti

Recent updates

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Third quarter 2024 earnings: EPS misses analyst expectations

Afya Limited Reaffirms Financial Guidance for the Year 2024

Investors Holding Back On Afya Limited (NASDAQ:AFYA)

Returns At Afya (NASDAQ:AFYA) Are On The Way Up

Afya Limited to Report Q3, 2024 Results on Nov 13, 2024

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Second quarter 2024 earnings: EPS exceeds analyst expectations

Afya Limited Updates Financial Guidance for the Year 2024

Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Afya Limited to Report Q2, 2024 Results on Aug 14, 2024

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Limited Announces the Resignation of Shobhna Mohn as a Member of the Board of Directors

Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Afya's Results Are Improving And The Market Is Undervaluing It

Afya Limited, Annual General Meeting, Jun 05, 2024

Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

Afya Limited Reports Unaudited Consolidated Write-Off Results for the First Quarter Ended March 31, 2024

Afya Limited Reports Unaudited Consolidated Write-Off Results for the First Quarter Ended March 31, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

AFYA: Mr Market Is Mistaken

Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Is Performing Well And Is A Buy

Full year 2023 earnings: EPS misses analyst expectations

Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Afya Limited Provides Earnings Guidance for the FY2024

Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

Afya Limited to Report Q4, 2023 Results on Mar 14, 2024

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Consensus EPS estimates fall by 14%

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Consensus EPS estimates increase by 11%

Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

Afya Limited to Report Q3, 2023 Results on Nov 13, 2023

What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Afya Limited to Report Q2, 2023 Results on Aug 28, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Afya Limited to Report Q1, 2023 Results on May 24, 2023

Afya Limited, Annual General Meeting, Jun 15, 2023

Investor sentiment improves as stock rises 19%

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates increase by 12%

Afya Announces Changes to Its Board of Directors

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Investor sentiment improved over the past week

Afya Limited to Report Q3, 2022 Results on Nov 21, 2022

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance

Investor sentiment improved over the past week

White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth

Afya Limited to Report Q2, 2022 Results on Aug 22, 2022

Consensus forecasts updated

First quarter 2022 earnings: EPS exceeds analyst expectations

Investor sentiment deteriorated over the past week

Erste Wv GÜTersloh Gmbh signed a basic agreement to acquire additional 2.4% stake in Afya Limited (NasdaqGS:AFYA) from Nicolau Carvalho Esteves Rosângela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd.

Less than half of directors are independent

Afya Limited Announces Changes to its Board of Directors

Afya Limited to Report Q1, 2022 Results on May 23, 2022

Afya Limited, Annual General Meeting, Apr 29, 2022

Afya: Margin And Organic Growth Struggles Remain Top Of Mind

Full year 2021 earnings: EPS misses analyst expectations

Investor sentiment improved over the past week

Consensus forecasts updated

Afya Limited to Report Q4, 2021 Results on Mar 31, 2022

Investor sentiment improved over the past week

Afya On A Grey Price Area

Consensus forecasts updated

Third quarter 2021 earnings: Revenues exceed analyst expectations